Cannell Thomas R

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return----------
Sale Success Rate----------

Carisma Therapeutics Inc.

Drugs » Biotechnology

President and CEO, Director:

Holdings: 672.39K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Orexigen Therapeutics, Inc.

Drugs » Drug Manufacturers - Other

EVP, COO, Pres Global Com Prod:

Holdings: 3.88K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--